HLB펩

196300KOSDAQ기초 의약물질 제조업

52.5 / 100

Reference Date: 2026-04-13

Financial Score17.0 / 40

News Sentiment17.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly up 2.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Pep is a company specializing in the synthesis of amino acids, peptides, and proteins, offering CDMO (Contract Development and Manufacturing Organization) services for pharmaceutical production. Utilizing solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) technologies, the company manufactures APIs (Active Pharmaceutical Ingredients) for new drug development and clinical trials, adhering to GMP (Good Manufacturing Practice) and CMC (Chemistry, Manufacturing, and Controls) standards.

Number of Employees

88people

Average Salary

35.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.454.0Point

PBR

2.63Industry Average 2.032.5Point

Higher than industry avg (caution)

ROE

-4.13Industry Average -4.293.5Point

Below industry avg

Debt Ratio

2.72Industry Average 6.616.5Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼7.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -55.2% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 70

Positive
HLB펩, 27년 펩타이드 기술 집약 '랩센' 출시… '스킨케어 시장 ...
HLB펩은 27년 펩타이드 기술을 집약한 더마 사이언스 브랜드 '랩센'을 론칭하며 스킨케어 시장에 본격 진출했습니다.
Positive
차백신연구소 최대주주 변경에 급등…HLB펩 日 CDMO 계약에 상승[바...
HLB펩은 일본 리프로셀과의 CDMO 계약으로 맞춤형 치료 시장에서 성장 모멘텀을 확보하며 투자심리를 자극했습니다.
Positive
HLB펩, 日 리프로셀과 신항원 펩타이드 CDMO 계약…맞춤형 치료 시...
HLB펩은 일본 리프로셀과 환자 맞춤형 신항원 펩타이드 원료의약품 공급 계약을 체결하며 글로벌 확장을 본격화했습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 7,280Won52-week high 10,41052-week low 6,250

1-month return4.0Point

1m +2.68% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral전환가액의조정 (제3회차)2026-04-08
Neutral주식등의대량보유상황보고서(일반)2026-04-03
Neutral정기주주총회결과2026-03-27
Neutral기업설명회(IR)개최2026-03-25
Neutral기업설명회(IR)개최2026-03-25